chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Large local reaction with redness and swelling around the deltoid. Swelling felt warm to the touch. Patients mother said that she had been treating him for a fever as well.
Red spot; muscle pain/muscle pain from her back to her buttocks; cannot move and does not want anyone touching it; This spontaneous case was reported by a consumer and describes the occurrence of MOVEMENT DISORDER (cannot move and does not want anyone touching it), RASH MACULAR (Red spot) and MYALGIA (muscle pain/muscle pain from her back to her buttocks) in a 97-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012120A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced MOVEMENT DISORDER (cannot move and does not want anyone touching it) and MYALGIA (muscle pain/muscle pain from her back to her buttocks). On 10-Feb-2021, the patient experienced RASH MACULAR (Red spot). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MOVEMENT DISORDER (cannot move and does not want anyone touching it), RASH MACULAR (Red spot) and MYALGIA (muscle pain/muscle pain from her back to her buttocks) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: follow-up reported on 22-Apr-2021 the patient said that they did not have any side effects after mentioning the reported events.She said they are doing fine and the events are not related to them and mentioned may be some one else but not them.
2 hours after receiving vaccine, he started having severe stomach cramps, couldn't eat anything, had diarrhea, chills, headache; his eyes were extremely watery and "filmy;" he still feels very weak 4 days later.
Headaches and dizziness observed but not attributed to vaccination until dangerously high blood pressure readings while attempting to donate blood.  Blood pressure reading was confirmed by pharmacy and physician and treatment prescribed.   Reviewed blood pressure history and see trend of slight increase after first dose of Pfizer Covid vaccine, another slight increase after 2nd dose then major spike after third dose.
Fainted initially second and third dose; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 25 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 21Mar2021 17:00 (Batch/Lot number: unknown) at the age of 25 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Location of injection: Arm Left), administration date: 01Mar2021, when the patient was 25 years old, for Covid-19 Immunization. The following information was reported: SYNCOPE (medically significant) with onset 2021, outcome "unknown", described as "Fainted initially second and third dose".  Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  The lot number for bnt162b2 was not provided and will be requested during follow up.
fever; chills; loss of taste; lack of appetite; weight loss; occasional nausea at times; low platelet count; This is a spontaneous report received from contactable reporter(s) (Other HCP and Consumer or other non HCP) for a sponsored program (060820).  A 57 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE X; MANUFACTUERER UNKNOWN (where X=1, 2, or number unknown), for COVID-19 immunization. The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "fever"; CHILLS (non-serious), outcome "unknown", described as "chills"; AGEUSIA (non-serious), outcome "unknown", described as "loss of taste"; DECREASED APPETITE (non-serious), outcome "recovering", described as "lack of appetite"; WEIGHT DECREASED (non-serious), outcome "unknown", described as "weight loss"; NAUSEA (non-serious), outcome "unknown", described as "occasional nausea at times"; PLATELET COUNT DECREASED (non-serious), outcome "unknown", described as "low platelet count". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Patient reports she missed therapy for 3 week. Two weeks (21Dec2021 to 04Jan2022) therapy was on hold due to low platelet count. Third week (05Jan2022 to 10Jan2022) patient had insurance issues and was unable to start therapy. During this 3 weeks of no therapy patient took covid booster (unknown date) and reports fever, chills, loss of taste, lack of appetite and weight loss. Patient restarted therapy on 11Jan2022 and also reports md asked her to take 75 mg every other day. unknown if md still wants her to have a week off. Advised to ask md on 18Jan2022 visit. Patient reports since last few days her appetite has improved a little but, she has occasional nausea at times. prescription: 75 mg daily for 21 days on and 7 days off. md aware.  The lot number for bnt162b2 was not provided and will be requested during follow up.
YF-VAX was administered to a patient through the intramuscular route instead of the subcutaneous route with no reported adverse event; Initial information received on 14-Jul-2022 regarding an unsolicited valid  non-serious case received from a other health professional. GMI number: 01190930  This case involves an unknown age/gender patient who was administered Yellow Fever Vaccine [YF-VAX] through the intramuscular route instead of the subcutaneous route with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received suspect Yellow Fever Vaccine (strength, formulation, dose, route, administration site, batch number and expiry date: unknown) via intramuscular route instead of the subcutaneous route with no reported adverse event (incorrect route of product administration) for prophylactic vaccination.   Action taken: Not applicable.  Outcome: Unknown.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Patient was sitting in the waiting area after receiving first dose of Pfizer vaccine and called store team member over and said that he felt dizzy. Upon assessing the patient he could not respond to questions and his eyes were glazed over. For a couple of minutes the patient was completely zoned out and could not respond. EMS was called to further evaluate the patient. After a few minutes the patient came back to and was able to respond to questions.
Rash on left neck, left scalp, left shoulder & left ear; burning sensation on left neck, left scalp, left shoulder & left ear; Light headache; Flush feeling; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via unspecified route of administration in left arm on 22Mar2021 at 12:00 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included lyme disease and the patient was allergic to nuts. The patient did not receive any other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 22Mar2021 at 12:15, the patient experienced rash on left neck, left scalp, left shoulder & left ear and burning sensation on left neck, left scalp, left shoulder & left ear, light headache and flush feeling. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures taken for rash on left neck, left scalp, left shoulder & left ear, burning sensation on left neck, left scalp, left shoulder & left ear, light headache and flush feeling included self-treatment with ZYRTEC-D tablet. The clinical outcomes of the events rash, burning sensation, headache and flushing was recovering.   Information about lot/batch number cannot be obtained. No further information is expected.
The vaccine triggered my POTS symptoms. As a result, I have been experiencing brain fog, dizziness, fatigue, headaches, tachycardia, muscle weakness, occasional slurred speech, and disorientation.
Patient is a 17 y.o. female who presents to the emergency department with chief complaint of shaking and fever. She reports that she received her HPV and meningococcal vaccination today as well as a TB skin test in preparation for international travel this summer. This evening, she went to a yoga class, and when she arrived home she started to feel unwell. She reports that she began experiencing aching in her arms that was spreading to her whole body. She states that during the event she felt shaky and achy. She started to feel very cold and "shaky." Her mom reports that her lips were even quivering, though she was still alert and able to communicate. She reported that she was crying and stated that she could not swallow while she was crying. During the event, the patient's mother appreciated a subjective fever and states the patient felt very warm. Mom attempted to measure a temperature, but they were unable to find a working thermometer. The patient's mother gave her 2 ADVIL which she was able to swallow without difficulty, then drove her to the ED for evaluation. Patient back to baseline by 2200.
Pt recv vax on 10/15/98;  1 hr later pt exp itching &hives at vax site (3X3); swollen lymph node to left clavicle area.
Chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and HEADACHE (headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown [Expire: Unknown]) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills) and HEADACHE (headache). At the time of the report, CHILLS (Chills) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications was not provided by the reporter Treatment information was not provided     This case was linked to MOD-2021-322952 (Patient Link).
Patient was given Pfizer bivalent booster on 10/08/22 at around 11:20am. About five minutes later, patient complained of feeling dizzy and sweaty.  No history of allergies or any health conditions. I had patient lie down on their back and elevate his legs. Cold compress was used on his neck, wrist, and face. His blood pressure and pulse were also checked and his values were in normal range.   After about 10 minutes, the patient started to feel better,. I had him stay in the pharmacy for 40 minutes for observation. Once I was assured he was fine, his mother took him home.  A follow up phone call was made to his mother to make sure he was doing well. Patient is feeling well.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Feb-2021 at 11:52 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 28-Feb-2021 at 11:52 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 33.68  Concomitant products were not provided.  28-Feb-2021 Excursion time was reported at 9am and 1pm with temperature as 27 and 26 degrees Fahrenheit respectively , total doses given for the day was 152 ,condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 24-Feb-2021, vial was moved to clinic on 27-Feb-2021. 20 vials were sent to clinic. Vaccine BUD date was 26-Mar-2021.  Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration.  Temperature recordings were taken using a Fisherbrand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Information has been received from an office manager concerning a 23 year old female patient who in 1988 was vaccinated with her first dose of MMR II (lot number unknown). The office manager reported that the patient received four doses of MMR II vaccination in childhood (1988, 1989, 1990 and 1992) and she was still testing negative titers. The patient denied any adverse effects. The patient sought unspecified medical attention. Additional information has been requested.
On 3/26/01, given Rubeola vaccine. On 3/28/01, reports respiratory difficulties, difficulty swallowing, sores in mouth, red spots, itching, nausea and dizziness. Was given Benadryl 50mg IM and 3 25mg caps. for later use. Labs: Strep and Mono were negative. 3/30/01, reports eyes red, irritated and light sensitive. No abrasions.
pallor, quivering or shaking in all extremities, altered mental state, starring, then sleepy ? postical, ? minor sz 1-2mins duration; APAP given T101.6;
PAIN, LIMITED RANGE OF MOTION, SWELLING AT INJECTION SITE AND ENTIRE UPPER ARM.
A:  Unina received Dose 1 of Pfizer COVID-19 vaccine 6/29.  Reports he started experiencing a "pin point, sharp stinging pain" "feels like a bee sting"  at the site where he received the COVID vaccine last Sunday/Monday (7/11 - 7/12).  He has continued to feel this pain off/on for a week now.  It mostly occurs when he uses his arm.  He rates the pain as a "4".  He is negative for any swelling, warmth, redness at the injection site.  He has had the body wide aches since the vaccination, no fever.  Denies any other symptoms of concern other than the bee sting sensation he will feel intermittently at the injection site.  Voices concern about getting the second dose of Pfizer.  Reports "everyone around me tells me not to get the second dose as it will get worse."
fever; hurting; so sick; cough; Initial information received on 06-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves an unknown age/gender patient who experienced fever, hurting, so sick and cough after receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (dose, route, site,lot number and expiry date unknown) for immunization.  On an unknown date ( 5 days later),  the patient developed a non-serious events fever (pyrexia), hurting (pain),  so sick (illness)  and cough (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the events (pyrexia, pain, illness, cough).  At time of reporting, the outcome was Unknown for all the events.
I felt fatigue and body aches after receiving the vaccine. In April 2023, developed pain in my right shoulder. I went to my doctor, and I have been referred to a physical therapist for therapy. In 11/2022, I began feeling symptoms of shortness of breath, fatigue and body aches. This lasted for several days. I tested negative for COVID-19 with a home test.  As of today, I continue to have shortness of breath. I do feel like I get sick with respiratory illnesses more frequently.
i have a Knot on injection site 10 days later after first moderna vaccine. Woke up in the middle of the night on 01/13/2021 with my arm hurting. when I woke up to come to work I went to feel for the pain and noticed the knot.  It is burning, itching, its red , it hurts and the area feels very warm today is 01/14/2021 and has not got any better. I spoke to a nurse yesterday and she said she would investigate and call me back. Later in the day she did and told me other people have had the issue and wanted me to call her the next morning. I did and she asked me to call because she didnt know how to help. they sent me here.
Swollen lymph node near breast on same side as injection; Low fever (100.2); Headache; Nausea; This is a spontaneous report from a contactable consumer. A 33-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EL3247), dose 2 via an unspecified route of administration, administered in Arm Left on 22Feb2021 11:30 (at the age of 33 years old) as 2nd dose, single for COVID-19 immunization. Medical history included anxiety from an unknown date and unknown if ongoing. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medication(s) included lisdexamfetamine mesilate (VYVANSE), desogestrel, ethinylestradiol (KARIVA), colecalciferol (D3), cyanocobalamin (B12 [CYANOCOBALAMIN]), fluoxetine hydrochloride (PROZAC), Welbutrin, L-Met. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EL3247), dose 1 via an unspecified route of administration, administered in Arm Left on 01Feb2021 01:00 PM as 1st dose, single for COVID-19 immunization. On 23Feb2021 12:00, after 24 hours of shot, the patient experienced low fever (100.2), headache, nausea and after 36 hours of shot, swollen lymph node near breast on same side as injection on 24Feb2021. The patient did not receive any treatment for the events.The patient underwent lab tests and procedures which included body temperature: 100.2 on 23Feb2021. The clinical outcome of the events was recovering.  No follow-up attempts are needed. No further information is expected.
Stomach - dull pain; I had a fever of 102 and over. It lasted a little less than 10 hours (the fever). The pain in stomach started getting progressively worse but still worse. I went to telehealth care but to be safe to go to get images. I spent the night in the hospital and they did a surgery and took out my appendicitis. I got my second shot February 12.
Patient had severe headache the evening of shot and it has continued. Patient also experienced nightmares, extreme sweating and migrating muscular pain.
Patient arrived, stated he wished to receive his first COVID Vaccine. Patient completed Registration paperwork, denied being previously vaccinated. Patient received Janssen vaccine as per protocol. When entering vaccine into state database, it was discovered that patient had previously received a total of three Pfizer vaccines {02/05/2021, 02/25/2021, & 09/01/2021}. Patient was unable to be reached by phone as he did not give a phone contact on registration.
Sindy fainted and had a convulsion/seizure immediately after receiving the first HPV shot. While she was out, she suddenly lifted her upper body, rolled her eyes, made a screeching noise (like scared) and stiffed her hands.
Sore arm for 1.5 days; This is a spontaneous report from a non-contactable pharmacist reporting for a patient. A non-pregnant female patient of unknown age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EL3247) intramuscularly in the left arm as a single dose on 09Mar2021 at 10:45 (age at vaccination unknown) for COVID-19 immunization. Medical history and concomitant medication were not reported. Patient did not have any allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 09Mar2021, the patient experienced sore arm and it lasted for 1.5 days. The patient did not receive any treatment for the event. The clinical outcome of the event sore arm was resolved on an unknown date of Mar2021 at the time of this report.   No follow-up attempts are possible No further information is expected.
Large baseball sized welt, redness, heat, pt had weakness and fatigue. Skin over vaccine area had area of fluid filled vesicles.
Shingles on torso after 2nd dose. Started at navel, then around right side to spine, then back. Painful. No headache/fever, SOB. Backache prior to shingles
irritability & fever 104 R;seen by MD sx started 4 days p/vax 18MAY98;seen by MD 20MAY w/diagnostic work up;?vax rxn;mom will contact PMD for counsel on future immunizations;